Specific phobias10 min read · 07 July 2026

Acrophobia Treatment: Overcoming Fear of Heights with VR

By Equipo clínico VRET

LinkedIn X / Twitter
TL;DR

Acrophobia affects a notable share of the adult population, and in vivo exposure is operationally difficult to arrange. Fear of heights was, in fact, the first disorder treated with virtual reality in a controlled trial, published by Rothbaum in 1995. Three decades later, available scenarios let clinicians work through balconies, stairways, bridges, and glass elevators with fine-grained gradation. This article describes the typical protocol, the role of SUDS ratings, and the points of transfer to real-world stimuli.

Editorial illustration: acrophobia — treating the fear of heights without climbing a real building, visual metaphor with a Mediterranean horizon.

A Common Phobia With Uneven Access to Treatment

Acrophobia is the specific phobia of heights, coded in the DSM-5-TR as a specific phobia of the situational or natural-environment type. Annual prevalence estimates in the adult population vary by methodology, typically falling between 3 and 7 percent. Its functional impact, although less conspicuous than that of other phobias, is not trivial: it limits access to certain jobs, constrains housing choices, and restricts leisure activities.

The evidence-based treatment is graded exposure. In vivo exposure is traditionally carried out with stairways, lookout points, terraces, glass elevators, and pedestrian bridges, in an ascending sequence. The operational challenge is having a varied repertoire of stimuli near the practice, calibrating height precisely, and maintaining the weekly frequency needed to consolidate inhibitory learning.

That is why acrophobia was, historically, the first disorder to undergo a controlled trial of VR exposure. Rothbaum and colleagues published a pilot study in the American Journal of Psychiatry in 1995, comparing VR exposure with a wait-list control. The positive result opened up the field of VRET and remains a required citation in any historical review.

The Foundational 1995 Study

Rothbaum's trial recruited patients with a clinical phobia of heights and assigned them to a VR exposure group (seven sessions over several weeks) or a wait-list. The scenarios reproduced a glass elevator, a bridge, and a railed terrace, with progressive height. Assessment combined self-report measures and a behavioral test.

Patients in the VR group showed clinically relevant improvement relative to the wait-list, with generalization to untrained in vivo stimuli. The study was small and the design still nascent, but it established that VR exposure could activate the phobic response and allow habituation in a manner analogous to real-world exposure.

Three decades later, the accumulated evidence (Parsons and Rizzo 2008, Powers and Emmelkamp 2008, Carl et al. 2019) corroborates the usefulness of VR in specific phobias, with large effect sizes versus control and non-inferiority relative to in vivo exposure. Acrophobia is still considered a good test bed for introducing VR into practice.

Available Environments and Typical Grading

Acrophobia environments available in VR practice typically include stairway sections (interior, exterior, spiral), railed balconies at different heights, building terraces, natural lookout points (cliffs, mountains), pedestrian bridges (covered, uncovered), elevated walkways, glass elevators, and flat building rooftops.

Grading crosses three dimensions. First, objective height (ground floor, second floor, tenth floor, fortieth floor). Second, degree of exposure (high opaque railing, medium railing, low transparent railing, no railing). Third, the activity demanded (standing still and observing, walking along the edge, leaning over, crouching, simulating a dropped object).

It is advisable to start at low levels across all three dimensions and advance in a stepwise fashion. Rapid progression on one dimension without consolidating the others generates SUDS spikes that can jeopardize adherence. A good practice is to hold two dimensions constant while varying the third.

Initial Assessment and Building the Hierarchy

Baseline assessment includes a structured clinical interview, a specific scale (such as the Acrophobia Questionnaire or the Heights Interpretation Questionnaire), a record of avoidance (which situations have been abandoned in the past year, which plans have been altered because of the phobia), and exploration of specific beliefs (fear of jumping voluntarily, fear of falling accidentally, fear of dizziness).

Building the hierarchy is a collaborative process. It is advisable to list between 15 and 20 real situations the patient identifies as feared and rank them by anticipatory SUDS. This list is the reference for designing VR sessions: the virtual scenario chosen for each session should correspond to the step due for work, neither excessively low nor too high.

It is worth clarifying from the first session that fear of falling accidentally and fear of jumping voluntarily call for distinct clinical management. The former responds well to graded exposure; the latter, known as L'appel du vide, is usually benign and requires specific psychoeducation to prevent a catastrophic interpretive spiral.

A typical operational sequence includes one assessment-and-formulation session, one psychoeducation-and-headset-adaptation session, four to six sessions of graded exposure through the hierarchy, one consolidation session with multiple tasks (leaning over, walking along the edge, simulating a dropped object), and a final transfer session with an in vivo exposure plan.

Session length runs between 45 and 60 effective minutes. Each session includes initial SUDS calibration, a core exposure phase with within-session repetition of the stimulus, and a closing segment recording what was learned. The interval between sessions is typically weekly.

The psychologist records peak SUDS, latency to habituation, intrusive cognitions, and observed safety behaviors (gripping the railing, looking at the ground, not approaching the edge). The progressive reduction of safety behaviors is one of the main indicators of progress.

The Role of SUDS Ratings and Patient Predictions

Subjective SUDS is the main metric during height exposure. It is recorded every one or two minutes during the session and paired with the patient's anticipatory predictions: how much SUDS they expect, how long they think habituation will take, and what intrusive cognitions they anticipate.

The contrast between prediction and observed outcome is informative and clinically useful. Patients tend to overestimate peak SUDS and underestimate the speed of habituation, which perpetuates anticipatory avoidance. Making this pattern explicit in every session consolidates a cognitive learning effect that habituation alone does not produce.

Session closure includes reviewing the predictions, recording the actual observations, and reformulating active beliefs. This seemingly minor cognitive component accounts for a good part of medium-term maintenance of the benefit.

Safety Behaviors and Their Deconditioning

Safety behaviors are actions the patient performs during exposure to reduce anxiety and that, paradoxically, perpetuate the phobia. In acrophobia, the most frequent are: gripping the railing tightly, avoiding looking at the edge, not approaching the ledge, keeping a preset minimum distance, fixing the gaze on a distant point, regulating breathing solely as a distraction, and mentally repeating reassuring phrases.

These behaviors are not inherently bad; many are reasonable in real situations with objective risk. The clinical problem arises when they are applied indiscriminately in low-risk situations and block the corrective information that exposure should provide. Explicit identification and progressive deconditioning are a core part of the protocol.

Deconditioning is approached in three steps. First, identify with the patient the safety behaviors active at each level of the hierarchy. Second, record their frequency during the session. Third, instruct the patient to drop one or two behaviors per session, keeping the rest, until they can face the scenario without any of them. This gradualness avoids an excessive anxiety surge and consolidates inhibitory learning.

Transfer to Real-World Stimuli and Relapse Prevention

Transfer is the ultimate success criterion. In vivo tasks should be planned from the start of the protocol, consistent with the VR hierarchy: climbing a flight of stairs, leaning over a familiar balcony, crossing a pedestrian bridge. Progression is coordinated with that week's VR session.

The final relapse-prevention session anticipates future situations that could reactivate the phobia (a trip, a change of residence, a professional event at height) and designs a preventive re-exposure plan. A single booster session at three months is usually enough to consolidate the outcome.

The VRET team has developed the heights exposure module with gradable environments (indoor, outdoor, natural) and controls for railing, platform, distance from the edge, and demanded task. The psychologist titrates intensity from their panel without leaving the session. If you would like to see how this could fit into your practice, you can book a demo with the team.

This article is for informational purposes for psychology professionals. It is not clinical advice for any individual case and does not replace the judgment of the licensed psychologist in charge. VRET is professional clinical-support software, not a CE-marked medical device.

Frequently asked questions

How many sessions does a VR acrophobia protocol usually require?

The usual protocol runs between 6 and 10 weekly sessions of 45-60 minutes. The exact duration depends on the initial level of avoidance, the presence of comorbidities, and how quickly intra-session habituation consolidates.

Can mild acrophobia be treated with VR without in-person sessions?

Unsupervised use of VR for acrophobia, outside the framework of psychological supervision, is not advisable as a clinical intervention. Professional supervision allows the hierarchy to be calibrated, safety behaviors to be managed, and transfer to be planned. The headset alone is a stimulus, not a treatment.

Does it work in patients with vertigo or vestibular problems?

Vestibular vertigo is a distinct clinical condition from acrophobia. It is advisable to rule it out with a prior medical evaluation. Sensitivity to cybersickness during VR can be an obstacle in some patients and usually subsides with short initial sessions and frequent pauses.

Is VR exposure valid without in vivo transfer?

In vivo transfer is necessary to consolidate generalization. VR is a bridge that lowers the initial barrier and allows the response to be rehearsed without physical risk, but the criterion for clinical success is the ability to face real situations that were previously avoided.

Can it be combined with pharmacological treatment?

Standard pharmacological treatment (SSRIs, situational beta-blockers) can coexist with the protocol. The use of benzodiazepines immediately before the session should be discouraged, given their interference with inhibitory learning. The decision rests with the responsible psychiatrist when active pharmacological treatment is in place.

Does the same protocol apply to children and adolescents?

Published protocols have mainly been studied in adults. Application in minors requires specific adaptation of the hierarchy, family supervision, a playful framing where appropriate, and informed consent from parents. Additional training in child clinical psychology is advisable.

VRET is professional clinical-support software, not a CE-marked medical device. Clinical supervision remains with the licensed psychologist in charge.